Product Name

  • Name

    Fluorocytosine

  • EINECS 217-968-7
  • CAS No. 2022-85-7
  • Article Data31
  • CAS DataBase
  • Density 1.73 g/cm3
  • Solubility 1.5g/100mL (25 °C) in water
  • Melting Point 298-300 °C (dec.)(lit.)
  • Formula C4H4FN3O
  • Boiling Point 298oC
  • Molecular Weight 129.094
  • Flash Point 96.4°C
  • Transport Information
  • Appearance white crystalline solid
  • Safety 22-24/25-45-36/37-36/37/39-27-26
  • Risk Codes 40-36/37/38
  • Molecular Structure Molecular Structure of 2022-85-7 (Fluorocytosine)
  • Hazard Symbols HarmfulXn, ToxicT, IrritantXi
  • Synonyms 5-Flurocytosine;4-amino-5-fluoro-3H-pyrimidin-2-one;Flucytosinum [INN-Latin];Ro 2-9915;Fluorcytosine;Flucytosin;Ancobon (TN);4-Amino-5-fluoro-2-pyrimidinol;Flucitosina [DCIT];5-Fluorocystosine;4-Amino-5-fluoro-2(1H)-pyrimidinone;Ancotyl;6-Amino-2-oxo-5-fluoropyrimidine;2-Hydroxy-4-amino-5-fluoropyrimidine;Flucytosine;Flucytosine (JP14/USP);5-FC;5FC;Alcobon;Cytosine, 5-fluoro- (6CI,7CI,8CI);5-Fluorocytosin;2(1H)-Pyrimidinone, 4-amino-5-fluoro- (8CI)(9CI);Ancotil;Ancobon;Cytosine, 5-fluoro-;
  • PSA 71.77000
  • LogP 0.07240

Synthetic route

2,5-difluoro-4-chloro-pyrimidine
99429-06-8

2,5-difluoro-4-chloro-pyrimidine

Flucytosine
2022-85-7

Flucytosine

Conditions
ConditionsYield
With ammonia In hydrogenchloride; ethanol; water98.1%
Cytosine
71-30-7

Cytosine

Flucytosine
2022-85-7

Flucytosine

Conditions
ConditionsYield
Stage #1: Cytosine With hydrogen fluoride at -15 - 0℃; Inert atmosphere;
Stage #2: at -20℃; for 4h; Inert atmosphere; Further stages;
95.7%
With 1,1,1,3',3',3'-hexafluoro-propanol; fluorine at 20℃; under 1125.11 Torr; Temperature; Pressure; Reagent/catalyst; Inert atmosphere;87.4%
With formic acid for 1.5h; Time; Flow reactor; Autoclave;63%
With formic acid; fluorine at 9℃; for 0.0833333h; Temperature; Concentration; Inert atmosphere;
4-amino-5-fluoro-2-methoxypyrimidine
1993-63-1

4-amino-5-fluoro-2-methoxypyrimidine

Flucytosine
2022-85-7

Flucytosine

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 40 - 60℃;95%
With hydrogenchloride In water at 100℃; for 4h;57%
N-acetyl-5-bromocytosine
945548-37-8

N-acetyl-5-bromocytosine

Flucytosine
2022-85-7

Flucytosine

Conditions
ConditionsYield
Stage #1: N-acetyl-5-bromocytosine With acetamide; potassium fluoride In N,N-dimethyl-formamide at 130℃; for 5h; Inert atmosphere;
Stage #2: With ammonia In methanol at 40℃; for 12h; Reagent/catalyst; Solvent; Temperature;
93%
N-9-fluorenylmethoxycarbonyl-5-bromocytosine

N-9-fluorenylmethoxycarbonyl-5-bromocytosine

Flucytosine
2022-85-7

Flucytosine

Conditions
ConditionsYield
Stage #1: N-9-fluorenylmethoxycarbonyl-5-bromocytosine With potassium fluoride; tetrabutyl ammonium fluoride In N,N-dimethyl-formamide at 110℃; for 10h; Inert atmosphere;
Stage #2: With sodium hydroxide In 1,4-dioxane at 50℃; for 2h; Inert atmosphere;
91.1%
C7H12FNO2

C7H12FNO2

urea
57-13-6

urea

Flucytosine
2022-85-7

Flucytosine

Conditions
ConditionsYield
Stage #1: C7H12FNO2; urea With sodium methylate In 5,5-dimethyl-1,3-cyclohexadiene at 80℃; for 1.5h; Large scale;
Stage #2: With hydrogenchloride In water at 0 - 25℃; for 2h; pH=6; pH-value; Temperature; Large scale;
84.2%
5-fluoropyrimidine-2,4-diamine

5-fluoropyrimidine-2,4-diamine

Flucytosine
2022-85-7

Flucytosine

Conditions
ConditionsYield
With sulfuric acid; water; sodium nitrite at 1 - 20℃; for 1.7h;83%
With sulfuric acid; sodium nitrite In water at 0 - 40℃;82%
Cytosine
71-30-7

Cytosine

A

Flucytosine
2022-85-7

Flucytosine

B

C4H5F2N3O2

C4H5F2N3O2

Conditions
ConditionsYield
With formic acid for 1.5h; Time; Flow reactor; Sealed tube;A 66%
B n/a
With formic acid; fluorine for 1.5h; Flow reactor; Overall yield = 64 %;
5-fluoro-2-(methylsulfonyl)pyrimidin-4-amine
1312324-60-9

5-fluoro-2-(methylsulfonyl)pyrimidin-4-amine

Flucytosine
2022-85-7

Flucytosine

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane; water at 20℃; for 3h;66%
β-D-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine
134379-77-4

β-D-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine

A

(2-furyl)methyl alcohol
98-00-0

(2-furyl)methyl alcohol

B

Flucytosine
2022-85-7

Flucytosine

Conditions
ConditionsYield
With acetic acid at 35 - 40℃; for 1h; pH=3 - 4; Product distribution; Further Variations:; pH-values; Temperatures;A 58%
B n/a
C4H4FN3O

C4H4FN3O

Flucytosine
2022-85-7

Flucytosine

Conditions
ConditionsYield
With ammonium hydroxide at 70 - 80℃; for 3h; Autoclave; Large scale;52%
5-fluoro-2-(methylsulfanyl)pyrimidin-4-amine
1310078-72-8

5-fluoro-2-(methylsulfanyl)pyrimidin-4-amine

Flucytosine
2022-85-7

Flucytosine

Conditions
ConditionsYield
With water; hydrogen bromide at 126℃; for 4h;51%
2-ethylsulfanyl-5-fluoro-pyrimidin-4-ylamine
701-87-1

2-ethylsulfanyl-5-fluoro-pyrimidin-4-ylamine

Flucytosine
2022-85-7

Flucytosine

Conditions
ConditionsYield
With hydrogen bromide
With hydrogen bromide
Cytosine
71-30-7

Cytosine

A

Flucytosine
2022-85-7

Flucytosine

B

4-Difluoramino-cytosin

4-Difluoramino-cytosin

Conditions
ConditionsYield
With fluorine In water at 0℃; for 1h;
C7H8FN3O4

C7H8FN3O4

Flucytosine
2022-85-7

Flucytosine

Conditions
ConditionsYield
With ammonia In methanol at 50℃; for 5h;26 g
C8H10FN3O4

C8H10FN3O4

Flucytosine
2022-85-7

Flucytosine

Conditions
ConditionsYield
With ammonia In methanol at 50℃; for 5h; Solvent; Large scale;2.67 kg
Flucytosine
2022-85-7

Flucytosine

benzoyl chloride
98-88-4

benzoyl chloride

N-benzoyl-5-fluorocytosine
10357-07-0

N-benzoyl-5-fluorocytosine

Conditions
ConditionsYield
With pyridine at 0 - 20℃; for 16h; Inert atmosphere;99%
Flucytosine
2022-85-7

Flucytosine

1-O-acetyl-5-O-(t-butyldiphenylsilyl)-2,3-dideoxy-2-fluoro-(L)-erythron-pentofuranose
202272-29-5

1-O-acetyl-5-O-(t-butyldiphenylsilyl)-2,3-dideoxy-2-fluoro-(L)-erythron-pentofuranose

(L)-5’-O-(t-butyldiphenylsilyl)-2’,3-dideoxy-2’-fluoro-5-fluorocytidine
202272-32-0

(L)-5’-O-(t-butyldiphenylsilyl)-2’,3-dideoxy-2’-fluoro-5-fluorocytidine

Conditions
ConditionsYield
Stage #1: Flucytosine With ammonium sulfate; 1,1,1,3,3,3-hexamethyl-disilazane for 1h;
Stage #2: 1-O-acetyl-5-O-(t-butyldiphenylsilyl)-2,3-dideoxy-2-fluoro-(L)-erythron-pentofuranose With trimethylsilyl trifluoromethanesulfonate In 1,2-dichloro-ethane at 20℃; for 4h; Inert atmosphere;
99%
Flucytosine
2022-85-7

Flucytosine

pentyl chloroformate
638-41-5

pentyl chloroformate

(5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamic acid amyl ester
862508-03-0

(5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamic acid amyl ester

Conditions
ConditionsYield
With pyridine; tetrabutylammomium bromide In dichloromethane at 20℃; for 1.5h; Reagent/catalyst;96%
With pyridine In dichloromethane at -10 - 20℃; for 2h; Concentration; Inert atmosphere;94.3%
With pyridine75%
With tetra(n-butyl)ammonium hydrogensulfate; triethylamine In chloroform; water at 5 - 10℃; for 1h;300 g
Flucytosine
2022-85-7

Flucytosine

acrylonitrile
107-13-1

acrylonitrile

3-(5-fluoro-1-cytosinyl)propionitrile

3-(5-fluoro-1-cytosinyl)propionitrile

Conditions
ConditionsYield
In ammonia for 1h;95%
With triethylamine In water at 100℃; for 0.0833333h; Michael addition; microwave irradiation;84%
Flucytosine
2022-85-7

Flucytosine

potassium acesulfame
55589-62-3

potassium acesulfame

5-fluorocytosine acesulfame potassium

5-fluorocytosine acesulfame potassium

Conditions
ConditionsYield
In methanol at 45℃; Concentration; Temperature; Solvent;95%
Flucytosine
2022-85-7

Flucytosine

acrylic acid methyl ester
292638-85-8

acrylic acid methyl ester

methyl 3-(5-fluoro-1-cytosinyl)propionate

methyl 3-(5-fluoro-1-cytosinyl)propionate

Conditions
ConditionsYield
In ammonia for 1h;94%
Flucytosine
2022-85-7

Flucytosine

ethyl 5-bromovalerate
14660-52-7

ethyl 5-bromovalerate

C11H16FN3O3
1379471-11-0

C11H16FN3O3

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 1h;93.3%
Flucytosine
2022-85-7

Flucytosine

C22H28FN3O11

C22H28FN3O11

Conditions
ConditionsYield
With aluminum (III) chloride In dichloromethane at 5 - 10℃; for 2h;92.7%
Flucytosine
2022-85-7

Flucytosine

1-O-acetyl-2,3,5-tri-O-benzoyl-D-ribofuranose
14215-97-5

1-O-acetyl-2,3,5-tri-O-benzoyl-D-ribofuranose

1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-5-fluorocytosine
53294-73-8

1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-5-fluorocytosine

Conditions
ConditionsYield
Stage #1: Flucytosine With 1,1,1,3,3,3-hexamethyl-disilazane In toluene for 3h; Heating;
Stage #2: 1-O-acetyl-2,3,5-tri-O-benzoyl-D-ribofuranose With trimethylsilyl trifluoromethanesulfonate In 1,2-dichloro-ethane at 20℃; for 8h;
91%
Flucytosine
2022-85-7

Flucytosine

2-amino-1,9-dihydro-6H-purin-6-one
73-40-5

2-amino-1,9-dihydro-6H-purin-6-one

copper(II) nitrate hydrate

copper(II) nitrate hydrate

water
7732-18-5

water

sodium hydroxide
1310-73-2

sodium hydroxide

[Cu2(5-fluorocytosine)(guanine)(OH)4(H2O)]*2H2O

[Cu2(5-fluorocytosine)(guanine)(OH)4(H2O)]*2H2O

Conditions
ConditionsYield
In ethanol; water byproducts: NaNO3; hydrated metal nitrate refluxed for about 10 hs in a mixt. of EtOH and triethyl orthoformate; 5-fluorocytozine and guanine added separately (molar ratio 2:1:1); mixt. refluxed for several hs; vol. reduced; pH adjusted to 7 (aq. NaOH soln.) with stirring; ppt. filtered; washed (EtOH, Et2O); oven-dried at 50-60°C; elem. anal.;91%
Flucytosine
2022-85-7

Flucytosine

(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (2R,5R)-5-(methylcarbonyloxy)-1,3-oxathiolane-2-carboxylate
147027-09-6

(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (2R,5R)-5-(methylcarbonyloxy)-1,3-oxathiolane-2-carboxylate

(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (2R,5S)-5-(4-amino-5-fluoro-2-oxo-1,2-dihydro-1-pyrimidinyl)-1,3-oxathialane-2-carboxylate
764659-72-5

(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (2R,5S)-5-(4-amino-5-fluoro-2-oxo-1,2-dihydro-1-pyrimidinyl)-1,3-oxathialane-2-carboxylate

Conditions
ConditionsYield
Stage #1: (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (2R,5R)-5-(methylcarbonyloxy)-1,3-oxathiolane-2-carboxylate With triethylsilane; iodine In dichloromethane at 0℃; for 1h; Inert atmosphere;
Stage #2: Flucytosine With N,O-bis-(trimethylsilyl)-acetamide In dichloromethane at 0 - 20℃; for 1h; Reagent/catalyst; Inert atmosphere; stereoselective reaction;
91%
Stage #1: Flucytosine With chloro-trimethyl-silane; 1,1,1,3,3,3-hexamethyl-disilazane at 25 - 130℃; Inert atmosphere;
Stage #2: (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (2R,5R)-5-(methylcarbonyloxy)-1,3-oxathiolane-2-carboxylate With zirconium(IV) chloride In dichloromethane at 25 - 30℃; for 6h; Inert atmosphere;
80%
Flucytosine
2022-85-7

Flucytosine

acrylic acid ammonium salt

acrylic acid ammonium salt

3-(5-fluoro-1-cytosinyl)propionic acid

3-(5-fluoro-1-cytosinyl)propionic acid

Conditions
ConditionsYield
In ammonia for 4h;90%
Flucytosine
2022-85-7

Flucytosine

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

N-(5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)-3,4,5-trimethoxybenzamide

N-(5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)-3,4,5-trimethoxybenzamide

Conditions
ConditionsYield
With pyridine at 100℃;90%
chloro-trimethyl-silane
75-77-4

chloro-trimethyl-silane

Flucytosine
2022-85-7

Flucytosine

=

=

Conditions
ConditionsYield
With 1,1,1,3,3,3-hexamethyl-disilazane In toluene at 100℃;90%
Flucytosine
2022-85-7

Flucytosine

2-amino-1,9-dihydro-6H-purin-6-one
73-40-5

2-amino-1,9-dihydro-6H-purin-6-one

zinc(II) nitrate hydrate

zinc(II) nitrate hydrate

water
7732-18-5

water

sodium hydroxide
1310-73-2

sodium hydroxide

[Zn2(5-fluorocytosine)(guanine)(OH)4(H2O)]*2H2O

[Zn2(5-fluorocytosine)(guanine)(OH)4(H2O)]*2H2O

Conditions
ConditionsYield
In ethanol; water byproducts: NaNO3; hydrated metal nitrate refluxed for about 10 hs in a mixt. of EtOH and triethyl orthoformate; 5-fluorocytozine and guanine added separately (molar ratio 2:1:1); mixt. refluxed for several hs; vol. reduced; pH adjusted to 7 (aq. NaOH soln.) with stirring; ppt. filtered; washed (EtOH, Et2O); oven-dried at 50-60°C; elem. anal.;89%
Flucytosine
2022-85-7

Flucytosine

C10H6BrF6NO
1215294-20-4

C10H6BrF6NO

C14H9F7N4O2
1215294-34-0

C14H9F7N4O2

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃;89%
Flucytosine
2022-85-7

Flucytosine

(2R,3R,4R,5R)-2-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-5-methyl-tetrahydrofuran-3,4-diyl diacetate
161599-46-8

(2R,3R,4R,5R)-2-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-5-methyl-tetrahydrofuran-3,4-diyl diacetate

Conditions
ConditionsYield
With titanium tetrachloride In dichloromethane at 10 - 20℃; for 4h; Solvent;88.6%
Stage #1: Flucytosine With ammonium sulfate; 1,1,1,3,3,3-hexamethyl-disilazane In toluene for 3h; Reflux;
Stage #2: 1,2,3-tri-O-acetyl-5-deoxy-β-D-ribofuranose With tin(IV) chloride In dichloromethane at -5℃; Inert atmosphere; Heating;
83.6%
Stage #1: Flucytosine With trifluorormethanesulfonic acid; 1,1,1,3,3,3-hexamethyl-disilazane In acetonitrile for 2h; Reflux;
Stage #2: 1,2,3-tri-O-acetyl-5-deoxy-β-D-ribofuranose With trifluorormethanesulfonic acid at 20 - 55℃;
80%
Flucytosine
2022-85-7

Flucytosine

1,2,3-tri-O-acetyl-α,β-D-ribofuranose-5-[phenylbis(isoamyl-L-aspartyl)]phosphate

1,2,3-tri-O-acetyl-α,β-D-ribofuranose-5-[phenylbis(isoamyl-L-aspartyl)]phosphate

2',3'-di-O-acetyl-5-fluorocytidine-5'-[phenylbis(isoamyl-L-aspartyl)]phosphate

2',3'-di-O-acetyl-5-fluorocytidine-5'-[phenylbis(isoamyl-L-aspartyl)]phosphate

Conditions
ConditionsYield
Stage #1: Flucytosine With ammonium sulfate; 1,1,1,3,3,3-hexamethyl-disilazane for 4h; Vorbrueggen Nucleoside Synthesis; Reflux;
Stage #2: 1,2,3-tri-O-acetyl-α,β-D-ribofuranose-5-[phenylbis(isoamyl-L-aspartyl)]phosphate With tin(IV) chloride In 1,2-dichloro-ethane at 20℃; for 3h; Reagent/catalyst; Solvent; Vorbrueggen Nucleoside Synthesis; diastereoselective reaction;
88%
Flucytosine
2022-85-7

Flucytosine

2-bromo-N-(4-fluorophenyl)acetamide
2195-44-0

2-bromo-N-(4-fluorophenyl)acetamide

C12H10F2N4O2
1215294-23-7

C12H10F2N4O2

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃;87%
Flucytosine
2022-85-7

Flucytosine

2-amino-1,9-dihydro-6H-purin-6-one
73-40-5

2-amino-1,9-dihydro-6H-purin-6-one

nickel(II) nitrate hydrate

nickel(II) nitrate hydrate

water
7732-18-5

water

sodium hydroxide
1310-73-2

sodium hydroxide

[Ni2(5-fluorocytosine)(guanine)(OH)4(H2O)]*2H2O

[Ni2(5-fluorocytosine)(guanine)(OH)4(H2O)]*2H2O

Conditions
ConditionsYield
In ethanol; water byproducts: NaNO3; hydrated metal nitrate refluxed for about 10 hs in a mixt. of EtOH and triethyl orthoformate; 5-fluorocytozine and guanine added separately (molar ratio 2:1:1); mixt. refluxed for several hs; vol. reduced; pH adjusted to 7 (aq. NaOH soln.) with stirring; ppt. filtered; washed (EtOH, Et2O); oven-dried at 50-60°C; elem. anal.;86%
2-bromo-N-(4-chloro-3-(trifluoromethyl)phenyl)acetamide

2-bromo-N-(4-chloro-3-(trifluoromethyl)phenyl)acetamide

Flucytosine
2022-85-7

Flucytosine

C13H9ClF4N4O2
1215294-09-9

C13H9ClF4N4O2

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃;86%
Flucytosine
2022-85-7

Flucytosine

(4-acetoxy-1,3-dioxan-2-yl)methyl benzoate

(4-acetoxy-1,3-dioxan-2-yl)methyl benzoate

β-{4-[4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl]-1,3-dioxan-2-yl}methyl benzoate

β-{4-[4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl]-1,3-dioxan-2-yl}methyl benzoate

Conditions
ConditionsYield
Stage #1: Flucytosine With ammonium sulfate; 1,1,1,3,3,3-hexamethyl-disilazane at 120℃; for 12h; Inert atmosphere;
Stage #2: (4-acetoxy-1,3-dioxan-2-yl)methyl benzoate With trimethylsilyl trifluoromethanesulfonate In dichloromethane at 0 - 20℃; Inert atmosphere; stereoselective reaction;
86%
Flucytosine
2022-85-7

Flucytosine

2-phenylimidazo[2,1-b][1,3]benzothiazole-3-carbaldehyde
127204-71-1

2-phenylimidazo[2,1-b][1,3]benzothiazole-3-carbaldehyde

C20H12FN5OS

C20H12FN5OS

Conditions
ConditionsYield
With acetic acid In ethanol for 24h; Reflux;85.1%
Flucytosine
2022-85-7

Flucytosine

C8H6BrClFNO
1215294-15-7

C8H6BrClFNO

C12H9ClF2N4O2
1215294-31-7

C12H9ClF2N4O2

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃;85%

Fluorocytosine Chemical Properties

Molecular structure of Fluorocytosine (CAS NO.2022-85-7) is:

Product Name: Fluorocytosine
CAS Registry Number: 2022-85-7
IUPAC Name: 6-amino-5-fluoro-1H-pyrimidin-2-one
Molecular Weight: 129.092463 [g/mol]
Molecular Formula: C4H4FN3O
XLogP3-AA: -0.9
H-Bond Donor: 2
H-Bond Acceptor: 3 
EINECS: 217-968-7
Melting Point: 298-300 °C (dec.)(lit.)
Surface Tension: 58.8 dyne/cm
Density: 1.73 g/cm3 
Storage temp.: 2-8 °C
Water Solubility: 1.5g/100mL (25 °C)
Sensitive: Light Sensitive 
Product Categories: PYRIMIDINE;Pyridines, Pyrimidines, Purines and Pteredines;Pyrimidine series;API;Phenylacetic acid;ketone;Nucleotides and Nucleosides;Antifungals for Research and Experimental Use;Biochemistry;Chemical Reagents for Pharmacology Research;Nucleobases and their analogs;Nucleosides, Nucleotides & Related Reagents;Nucleic acids;Bases & Related Reagents;Nucleotides

Fluorocytosine Uses

 Fluorocytosine (CAS NO.2022-85-7) is a synthetic antimycotic drug.

Fluorocytosine Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD12 oral 500mg/kg (500mg/kg)   British UK Patent Application. Vol. #2067993,
mouse LD50 intraperitoneal 1190mg/kg (1190mg/kg)   Antimicrobial Agents and Chemotherapy Vol. -, Pg. 566, 1963.
mouse LD50 intravenous 500mg/kg (500mg/kg)   Antimicrobial Agents and Chemotherapy Vol. -, Pg. 566, 1963.
mouse LD50 subcutaneous 1gm/kg (1000mg/kg)   Chemotherapy Vol. 25, Pg. 54, 1979.
rat LD50 intraperitoneal 3811mg/kg (3811mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 710, 1979.
rat LD50 intravenous > 600mg/kg (600mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 710, 1979.
rat LD50 oral > 15gm/kg (15000mg/kg)   Drugs in Japan Vol. 6, Pg. 699, 1982.
rat LD50 subcutaneous 3336mg/kg (3336mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 21, Pg. 935, 1979.
women TDLo oral 1080mg/kg/10D (1080mg/kg) BRAIN AND COVERINGS: OTHER DEGENERATIVE CHANGES

BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: ATAXIA
European Journal of Clinical Pharmacology. Vol. 51, 505.

Fluorocytosine Safety Profile

Hazard Codes: HarmfulXn,Xi ;ToxicT
Risk Statements: 40-36/37/38 
R40:Limited evidence of a carcinogenic effect. 
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 22-24/25-45-36/37-36/37/39-27-26 
S22:Do not breathe dust. 
S24/25:Avoid contact with skin and eyes. 
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) 
S36/37:Wear suitable protective clothing and gloves. 
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection. 
S27:Take off immediately all contaminated clothing. 
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
WGK Germany: 2
RTECS: HA6040000
F: 10-23
Hazard Note: Toxic/Light Sensitive
HazardClass: IRRITANT, LIGHT SENSITIVE

Fluorocytosine Specification

 Fluorocytosine , its cas register number is 2022-85-7. It also can be called 2-Hydroxy-4-amino-5-fluoropyrimidine ; 4-Amino-5-fluoro-2(1H)-pyrimidinone ; 5-Fluorocytosine ; Alcobon ; Ancobon ; Ancotil .It is a white crystalline solid.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View